Search

Search Constraints

You searched for: Author/Creator Lim, Ho Yeong

Search Results

1. A multi-center, open-label, randomized phase III trial of first-line chemotherapy with capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer. Issue 3 (May 2017)

2. An Open‐Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM‐080301 in Subjects with Advanced Hepatocellular Carcinoma. (31st December 2018)

3. Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single‐arm, phase 2 study. Issue 24 (20th August 2021)

4. Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population. (February 2023)

6. Clinical and molecular distinctions in patients with refractory colon cancer who benefit from regorafenib treatment. (November 2020)

7. Clinical Application of Targeted Deep Sequencing in Solid‐Cancer Patients and Utility for Biomarker‐Selected Clinical Trials. (12th July 2017)

8. Clinical parameters predictive of outcomes in sorafenib‐treated patients with advanced hepatocellular carcinoma. (21st April 2013)

10. Clinical Significance of Mucinous Rectal Adenocarcinoma following Preoperative Chemoradiotherapy and Curative Surgery. Issue 1 (January 2016)